Genentech

GPS navigation to pins and multiple markers on route

Genentech builds autoimmune Repertoire with $765M deal

Genentech will pay Repertoire $35 million upfront and up to $730 million in milestones to develop T-cell-targeted medicines for an autoimmune disease.

Darren Incorvaia Apr 23, 2025 7:00am

Roche's $50B US investment to include upcoming Boston CVRM site

Apr 22, 2025 5:10am

Harvard University School of Engineering and Applied Sciences

Roche to house its CVRM research work at new Boston hub

Mar 7, 2025 9:40am

Cartoon of medical cross made by crowd of people on white background

Amid political uncertainty, pharmas double down on trial diversity

Feb 27, 2025 8:00am

Genentech archives diversity reports amid site construction

Feb 13, 2025 2:29pm

graphic image of different colored hands shaking

Kineta sells Genentech, Merck deals to investor ahead of merger

Feb 10, 2025 7:45am